Pot Stock Aphria Makes Dramatic Reversal Even As Short-Seller Piles On – Investor's Business Daily

Marijuana stocks pared losses and Aphria (APHA) reversed sharply higher as the Canadian cannabis producer battled a short-seller that alleged acquisitions were rigged to surreptitiously enrich company insiders.

X

Aphria said it named an independent panel to review its deal. But even as it tried to contain the fallout from an earlier short-seller report, one of the firms behind it published new allegations about the company later Thursday afternoon.

That firm, Hindenburg Research, said Thursday that it dug up “multiple irregularities” related to a company called Liberty Health Sciences, which the firm said was backed by Aprhia.

Those findings, Hindenburg alleged, “raise more questions around believed undisclosed insider self-dealing.”

Earlier Thursday, Aphria, in a statement, said its board “reiterated its confidence” in the process leading up to the Latin American acquisitions. The statement said the board stood by Aphria’s Latin American operations as well.

“However,” Aphria said, “in the face of inaccurate and misleading accusations by certain short-sellers, whose sole interest is in profiting from a decline in the Company’s shares, it is undertaking a comprehensive review, led by a Special Committee of independent directors of these, and any other, allegations in the interest of protecting Aphria shareholders.”

Aphria said John M. Herhalt, an independent director, would chair the committee. Directors Shlomo Bibas and Tom Looney would also be on the committee. Aphria said each member was independent and joined the board after the Latin American acquisitions closed.

CEO Vic Neufeld added: “We are committed to protecting our shareholders and restoring market confidence by confirming all the facts through an independent process to rebut innuendo and deception.”

According to a BNN Bloomberg story on Wednesday, Neufeld said the company would soon provide a “line-by-line” response to the report. Quintessential Capital and Hindenburg Research released the

Read More Here...

This entry was posted in Hemp, MMJ, Cannabis Stocks News. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback.

Leave a Reply

Your email address will not be published. Required fields are marked *

Your email address will never be published.